PROMIS and Mobility Evaluation in Sarcoma Patients
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- University of Calgary
- Study ID
- NCT07227961
- Status
- Recruiting
Conditions
- Giant Cell Tumor of Bone
- Sarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Surgery — PROCEDUREAny type of surgery performed to remove the primary tumor including resection, amputation, and bone stabilization.
Study Details
The goal of this is to validate the Patient-Reported Outcomes Measurement Information System (PROMIS) in sarcoma patients undergoing surgery, and to evaluate a novel smartphone app for collecting mobility data. The goals of the study include to: 1. Validate PROMIS as a patient outcome measure in sarcoma 2. Assess the effectiveness of a novel app for administering questionnaires and collecting mobility metrics 3. Compare PROMIS scores and mobility metrics to better evaluate recovery trajectories after surgery Participants will complete PROMIS questionnaires at regularly scheduled intervals using the smartphone app. Questionnaires will be completed pre-operatively and at 6 weeks, 12 weeks, 6 months, and 12 months post-operatively. Additionally, the app will passively track mobility metrics such as daily step count, stairs climbed, and gait parameters to compare with PROMIS scores.
Key Dates
- Start date
- Jul 1, 2025
- Status verified
- Oct 2025
- Primary completion
- Jun 30, 2030
- Completion
- Jan 1, 2031
Study Design
- Enrollment
- 800 participants (estimated)
Arms
- Arm: SarcomaAdult patients treated with surgery for bone and soft tissue sarcoma, and giant cell tumor of bone
Primary Outcome Measure
Step count [ Time Frame: From enrolment to one year post-operative ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Phoenix | Arizona | 85054 | Krista A Goulding, MD MPH (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic | Rochester | Minnesota | 55905 | Matthew T Houdek, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Phoenix, AZ
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · ImmVira Pharma Co. Ltd · Gilbert, Arizona
- GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2PHASE1 · Recruiting · Y-mAbs Therapeutics · Scottsdale, Arizona
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruiting · Alliance for Clinical Trials in Oncology · Anchorage, Alaska